Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.35 |
| ▸ | FLT3 | P36888 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | TERT | O14746 | 1/20 | 0.32 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL18890705 | 0.98 | LMNA (0.37) | LMNATDP1TAS2R14FLT3PTPN1 | |
| SCHEMBL2817421 | 0.87 | NPBWR1 (0.42) | LMNATDP1NPBWR1HDAC6 | |
| Water SCHEMBL18890706 | 0.85 | NPBWR1 (0.41) | LMNATDP1NPBWR1HDAC6 | |
| SCHEMBL3391197 | 0.83 | MAPT (0.44) | LMNATDP1 | |
| SCHEMBL1160168 | 0.83 | HDAC6 (0.46) | LMNATDP1TAS2R14HDAC6L3MBTL1 | |
| Water SCHEMBL28362650 | 0.82 | HDAC6 (0.44) | TDP1TAS2R14HDAC6L3MBTL1PARP1 | |
| SCHEMBL2817420 | 0.82 | HDAC6 (0.44) | LMNATDP1TAS2R14HDAC6L3MBTL1 | |
| Water SCHEMBL28362573 | 0.81 | HDAC6 (0.43) | TDP1TAS2R14HDAC6L3MBTL1PARP1 | |
| Ensulizole SCHEMBL3173641 | 0.75 | NPBWR1 (0.58) | LMNANPBWR1HDAC6 | |
| SCHEMBL16134559 | 0.73 | LMNA (0.47) | LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 516 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118272876-A | Method for manufacturing electrolytic copper foil with high tensile strength after heat treatment | 陕西未来尖端材料科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118241268-A | High tensile strength electrolytic copper foil additive, electrolytic copper foil and preparation method | 陕西未来尖端材料科技有限公司 | 2024-06-25 | — | — | CN | claimed |
| EP-4385496-A2 | COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM BODY SURFACE LESIONS AND FROM ORAL CAVITY | DEBx Medical Holding BV (NL) | 2024-06-19 | — | — | EP | claimed |
| EP-3923923-B1 | COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM BODY SURFACE LESIONS AND FROM ORAL CAVITY | DEBx Medical Holding BV (NL) | 2024-06-05 | — | — | EP | claimed |
| WO-2023219269-A1 | METHOD FOR CONTROLLING PROPERTIES OF ELECTROLYTIC COPPER FOIL, AND MANUFACTURING METHOD THEREFOR | 고려아연 주식회사 | 2023-11-16 | — | — | WO | claimed |
| CN-115012007-B | Copper-graphene electroplating solution, copper-graphene composite foil and preparation method thereof | 江西理工大学 | 2023-09-26 | — | — | CN | claimed |
| CN-113373482-B | Pulse copper electroplating additive, electroplating solution and application of electroplating solution | 深圳市贝加电子材料有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-113369489-B | Luminescent silver nanocluster and preparation method and application thereof | 山西大学 | 2023-03-07 | — | — | CN | claimed |
| US-20220401392-A1 | Compositions for removing necrotic or infected tissues from body surface lesions and from oral cavity | DEBx Medical Holding B.V. (NL) | 2022-12-22 | — | — | US | claimed |
| CN-115012007-A | Copper-graphene electroplating solution, copper-graphene composite foil and preparation method thereof | 江西理工大学 | 2022-09-06 | — | — | CN | claimed |
| EP-1276557-A2 | SIMULATED ACTIVITY OF PROTEIN A DISPLAYED BY LIGANDS ATTACHED TO A CELLULOSE BEAD SURFACE | Accurate Polymers, Ltd. (US) | 2003-01-22 | — | — | EP | claimed |
| US-20020156333-A1 | Instant degradation of plastics into soluble non-toxic products | ROSEN OREN (IL) | 2002-10-24 | — | — | US | claimed |
| WO-2002062924-A1 | INSTANT DEGRADATION OF PLASTICS TO SOLUBLE NON-TOXIC PRODUCTS | ROSEN OREN (IL) | 2002-08-15 | — | — | WO | claimed |
| EP-0944564-B1 | HALOGEN EXCHANGE REACTIONS AND USES THEREOF | ALBEMARLE CORP (US) | 2002-03-20 | — | — | EP | claimed |
| US-20010045384-A1 | Simulated activity of protein a displayed by ligands attached to a cellulose bead surface | ACCURATE POLYMERS, LTD. | 2001-11-29 | — | — | US | claimed |
| WO-2001083515-A2 | SIMULATED ACTIVITY OF PROTEIN A DISPLAYED BY LIGANDS ATTACHED TO A CELLULOSE BEAD SURFACE | ACCURATE POLYMERS, INC. (US) | 2001-11-08 | — | — | WO | claimed |
| US-5187050-A | Adding single replenisher containaing 3-pyrazolidone developer | FUJI PHOTO FILM CO., LTD. (JP) | 1993-02-16 | — | — | US | claimed |
| EP-0164120-B1 | A METHOD FOR HIGH CONTRAST DEVELOPMENT OF A SILVER HALIDE PHOTOGRAPHIC MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1989-11-15 | — | — | EP | claimed |
| US-4668605-A | SILVER HALIDE MATERIAL CONTAINING A HYDRAZINE DERIVATIVE | FUJI PHOTO FILM CO., LTD. (JP) | 1987-05-26 | — | — | US | claimed |
| EP-0164120-A2 | A method for high contrast development of a silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1985-12-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220401392-A1 | Compositions for removing necrotic or infected tissues from body surface lesions and from oral cavity | TAS2R5, TAS2R40, TST | LMNA 4564/4885TDP1 3642/4885TAS2R14 30/4885 |
| US-20020156333-A1 | Instant degradation of plastics into soluble non-toxic products | REL, STRA6, RARA | LMNA 1258/4885TDP1 4235/4885TAS2R14 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.